Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness Study of the Biolinq MicroArray Intradermal Continuous Glucose Biowearable System

NCT06229743 is registered in ClinicalTrials.gov with Biolinq Inc. as lead sponsor.

NCT NCT06229743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06229743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness Study of the Biolinq MicroArray Intradermal Continuous Glucose Biowearable System
Lead sponsor
Biolinq Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2024
Completion date
June 10, 2024
Enrollment
247 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus